Expression of moesin and CD44 is associated with poor prognosis in gastric adenocarcinoma
Address for correspondence: B-h Kim, MD, PhD, Department of Pathology, Korea University Guro Hospital, Korea University College of Medicine, 97 Gurodong, Guro-gu, Seoul 152-703, Korea. e-mail: firstname.lastname@example.org
CD44 has been reported as a negative prognostic marker in gastric cancer. It interacts with moesin in epithelial–mesenchymal transition. To date, to our knowledge, there has been no clinical study dealing with the relationship between moesin and gastric adenocarcinoma. We analysed the expression of moesin and CD44 in gastric adenocarcinoma tissue, and correlations with clinicopathological factors.
Methods and results
A retrospective analysis was made of 430 patients who had undergone gastrectomy at the Korea University Guro Hospital between 2002 and 2005 for gastric adenocarcinoma. Using tissue microarray and immunohistochemical staining, moesin expression was observed in 192 (44.7%) cases; it was associated significantly with poorly differentiated histology, invasion depth, lymph node metastasis, lymphatic invasion and advanced pathological TNM stage. CD44 expression was not correlated with clinicopathological features or moesin expression. Moesin expression was a strong predictor of lymph node metastasis in logistic regression analysis. Both moesin expression and CD44 expression were associated significantly with poor overall survival in univariate analysis. Furthermore, in multivariate analysis, moesin and CD44 were independent markers of poor prognosis, along with pathological TNM stage and older patient age.
Moesin expression and CD44 expression might be useful markers of poor prognosis in gastric adenocarcinoma.